Breast cancer specimens contain higher concentrations of PLA2 than benign breast tissues, and low PLA2 activity is associated with longer disease-free intervals and survival even though no relationship was noted between PLA and ER or progesterone receptor status (Yamashita et al. 1993, 1994, 1995). The gene discussed is PLA2G2A; the disease is breast carcinoma.